Clinical Trial

A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

Study acronym: VALUE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The main objective of this study is: To assess the efficacy and safety of EscharEx (EX-03 5% formulation) compared to placebo control,in debridement and wound bed preparation of Venous Leg Ulcers (VLU).
Protocol Amendment History 1 change
notable Trial sites expanded: 5 -> 25 locations 2026-04-03
Trial Details
NCT Number NCT06568627
Lead Sponsor MediWound Ltd
Conditions Venous Leg Ulcer (VLU)
Enrollment 216 participants
Start Date 2025-06-01
Primary Completion 2026-12 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-02